Associate Director, Marketing

Primary Responsibilities

LX2006 launch strategy and brand planning: Partner with the Senior Director, Marketing to enhance and execute the LX2006 US launch strategy and brand plan, including strategic imperatives, positioning, target patient definition and the pre-launch market development plan. Translate strategy into an integrated launch roadmap and prepare materials for Launch Readiness Reviews, senior leadership and Board discussions as well as investor calls. Define launch KPIs and the analytics and CRM capabilities needed to track launch performance
Launch readiness leadership: Serve as a core member of the cross-functional US and ex-US Launch Readiness Teams. Drive launch timelines, deliverables, interdependencies, risks and decisions across Commercial, Medical Affairs, Patient Affairs, Market Access/HEOR, Regulatory, Clinical, Legal and CMC
Customer insights and market research: Lead the HCP, patient/caregiver, and payer research program for LX2006 (e.g., awareness, trial and usage tracking, demand studies, message and concept testing, advisory boards). Distill findings into clear recommendations that shape positioning, patient segmentation, evidence generation and lifecycle decisions
Competitive intelligence: Own the Friedreich ataxia (FA) competitive intelligence program, including key intelligence questions, monitoring of competitor clinical, regulatory and commercial activity, scenario planning and war gaming, and regular updates to leadership and cross-functional partners
Brand development and campaigns: Lead global brand development for LX2006, including brand naming and trademark activities, brand identity and brand book. Develop and deploy unbranded disease-awareness and branded HCP and patient campaigns across channels, managing creative and media agencies and the medical/legal/regulatory (MLR) review process
Customer targeting and treatment center readiness: Build and refine the prescriber, account and treatment center universe across neurology and cardiology using claims and other third-party data. Define targeting and segmentation, and partner with Medical and Market Access on treatment center mapping, readiness assessments and referral pathways
HCP and KOL engagement: Develop and execute the commercial HCP and KOL engagement plan (e.g., KOL steering committee, peer-to-peer programs, advisory boards, medical congress presence) in compliant partnership with Medical Affairs
Global launch planning: Support ex-US launch sequencing and go-to-market planning, ensuring global brand strategy, insights and materials can be adapted for priority markets as LX2006 expands beyond the US
Field launch readiness: Develop core launch materials (e.g., sales aids, leave-behinds, websites, congress assets) and contribute to field training, launch meeting and plan-of-action planning ahead of field deployment
LX2020 early commercial planning: Support early commercial planning for LX2020 in PKP2-associated arrhythmogenic cardiomyopathy, including target product profile development, HCP and payer research, patient segmentation, market sizing and commercial input to pivotal trial design, leveraging synergies with LX2006
Budget and vendor management: Manage marketing budgets, statements of work and vendor relationships across market research, data, creative and strategy partners; track spend against plan and contribute to annual budget planning
Team building: Help scale the team as we get closer to launch and contribute to a collaborative cross-functional commercial mindset culture 

Required Skills and Qualifications

MBA or other advanced degree required
Minimum of 7 years of experience in the biopharmaceutical industry, including direct marketing experience on a launch brand and/or in rare disease. Gene therapy marketing experience is a plus
Demonstrated experience developing brand strategy, positioning and HCP and/or patient campaigns, including agency management and MLR review
Hands-on experience designing and managing primary market research and translating insights into strategy
Strong analytical skills, with comfort working with claims and other secondary data, forecasts and market sizing
Exceptional project management skills and a proven ability to lead cross-functional teams without direct authority while managing multiple workstreams
Excellent written and verbal communication skills, including the ability to synthesize complex information into concise, executive-ready narratives for senior leadership and the Board
Working knowledge of US compliance requirements governing pre-approval and promotional activities
Self-starter with a builder mindset who thrives in a lean, fast-paced, pre-commercial environment
Ability to travel as needed (e.g., medical congresses, advisory boards, vendor and treatment center meetings) 

Preferred Skills and Qualifications

Gene therapy or cell and gene therapy launch experience (significant plus)
Prior management or strategy consulting experience in life sciences
Experience in cardiology and/or neurology marketing
Exposure to market access, pricing and reimbursement for high-cost, one-time therapies
Global or ex-US launch experience, including familiarity with HTA requirements